Quattrocchi F, Karnes H T, Robinson J D, Hendeles L
Ther Drug Monit. 1983;5(3):359-62. doi: 10.1097/00007691-198309000-00020.
Using the EMIT assay, we tested clinical samples from patients receiving 12 commonly monitored drugs to evaluate the effect of serum separator gel contained in serum separator blood collection tubes (SST) (Becton-Dickinson). There were significant concentration decreases for lidocaine, pentobarbital, and phenytoin. In vitro experiments demonstrated that this effect on phenytoin was dependent on time of exposure to the gel and volume of whole blood, but was not dependent on the presence of red blood cells or initial concentration. Bias attributed to the use of SST could interfere with the usefulness of clinical results at the upper and lower limits of the therapeutic range. This problem can be minimized by processing samples of at least 2 ml within 1 h.
我们使用酶放大免疫测定技术(EMIT),对接受12种常用监测药物治疗的患者的临床样本进行检测,以评估含血清分离胶的血清分离采血管(SST)(贝克顿-迪金森公司生产)的影响。利多卡因、戊巴比妥和苯妥英的浓度出现显著下降。体外实验表明,这种对苯妥英的影响取决于与凝胶接触的时间和全血体积,但不取决于红细胞的存在或初始浓度。使用SST造成的偏差可能会干扰治疗范围上限和下限处临床结果的有效性。通过在1小时内处理至少2毫升的样本,这个问题可以得到最小化。